Company Monitoring Page for Keryx

latest headlines for company on cafepharma

Biotechs And Their Trials By Fire
Seeking Alpha
Mon, 11/7/11 - 11:57 am
Tags:
MannKind, Keryx, Dendreon, Arena, Biocryst, Aeterna Zentaris, Advanced Cell Technologies
Keryx Biopharmaceuticals: Volatility Could Potentially Produce Monetary Gains
Seeking Alpha
Sun, 10/23/11 - 10:51 am
Tags:
Keryx, Aeterna Zentaris, Perifisone, Zerenex
Keryx And Aeterna Zentaris: 2 Great Buys With Good Odds On FDA Approval
Seeking Alpha
Fri, 10/21/11 - 10:11 am
Tags:
Keryx, FDA, Aeterna Zentaris, colorectal cancer, Perifosine Akt inhibitor
Keryx: Readers React to Perifosine Prediction
TheStreet.com
Wed, 10/19/11 - 09:41 am
Tags:
Keryx, Perifisone
Using Options In Speculative Biotech Investing
Seeking Alpha
Mon, 10/10/11 - 11:26 am
Tags:
Antares Pharma, Aeterna Zentaris, options, Dendreon, BioSante, Keryx, Oncothyreon
The Keryx Rebound Is For Real
Seeking Alpha
Thu, 10/6/11 - 01:17 pm
Tags:
Keryx, Perifisone
8 Speculative Biotech Buys Based On Last Quarter's Biggest Movers
Seeking Alpha
Mon, 10/3/11 - 12:37 pm
Tags:
Achillion, Aeterna Zentaris, Antigenics, Ariad, Amylin, Amarin, BioDelivery Sciences, Cyclacel, Geron, Dendreon, PharmAthene, Zalicus, Human Genome Sciences, Keryx, Peregrine Pharmaceuticals, SIGA technologies, YM BioSciences
7 Cheap Biotechs That Could Double Or Triple By Next Year
Seeking Alpha
Mon, 09/12/11 - 01:28 pm
Tags:
Inhibitex, Optimer, Catalyst, Rexahn, Keryx, BioSante, Aeterna Zentaris
Keryx CEO: Selling Company 'Top Priority'
TheStreet.com
Thu, 09/8/11 - 11:14 am
Tags:
Keryx, M&A, colon cancer, perifosine
Keryx Shares Surged: What You Need to Know
Motley Fool
Wed, 08/31/11 - 02:18 pm
Tags:
Keryx, perifosine, colorectal cancer
12 Biotech Stocks the Insiders Are Buying
Motley Fool
Sat, 08/20/11 - 10:09 pm
Tags:
Ligand, Halozyme, Ziopharm, OPKO Health, Theravance, Celgene, Human Genome Sciences, BioSante, Keryx, GTx, SIGA technologies, SciClone Pharmaceuticals
6 Companies That Could Revolutionize Medicine -- And Portfolios
Seeking Alpha
Fri, 08/19/11 - 09:13 am
Tags:
Opexa, RXi Pharmaceuticals, Oncothyreon, Celldex, Advanced Cell Technologies, Keryx
5 Cheap Biotech Stocks That May Rebound Ahead of the Market
Seeking Alpha
Fri, 08/12/11 - 12:43 pm
Tags:
BioSante, Chelsea Therapeutics, Dendreon, Keryx, Opexa
2 Biotechs, 1 Promising Cancer Drug
Motley Fool
Sat, 07/30/11 - 10:06 am
Tags:
Aeterna Zentaris, Keryx, perifosine, colorectal cancer, Roche, Xeloda
The 15 Most-Watched BioPharma Stocks
Motley Fool
Wed, 07/13/11 - 04:53 pm
Tags:
MannKind, Celgene, Amarin, Vertex Pharmaceuticals, BioSante, Keryx, Amylin, Regeneron, Immunogen, Cubist Pharmaceuticals, Isis Pharmaceuticals, Sunesis, OPKO Health, SciClone, Cephalon
Dendreon Leads the 'Now Generation' For Cancer Immunotherapeutic Treatment
Seeking Alpha
Mon, 07/4/11 - 09:20 am
Tags:
Dendreon, prostate cancer, cancer immunotherapy, Cel-Sci, Cell Therapeutics, ImmunoCellular, Keryx, Teva Pharmaceuticals, Oncothyreon
5 Dirt Cheap Biotech Stocks Poised to Triple
Seeking Alpha
Tue, 06/28/11 - 08:53 am
Tags:
Adventrx, Chelsea Therapeutics, Keryx, Palatin, Rexahn
Medicine's Next Revolution: 2 Cancer Vaccines With the Greatest Potential
Seeking Alpha
Sun, 06/26/11 - 12:03 pm
Tags:
Dendreon, prostate cancer, DN24-02, Neuvenge, Provenge, Oncothyreon, Stimuvax, colorectal cancer, breast cancer, Keryx
8 Potential Biotech Acquisition Candidates
Seeking Alpha
Mon, 06/20/11 - 09:30 am
Tags:
biotech, M&A, Arena Pharmaceuticals, Biomarin, Dendreon, Human Genome Sciences, Keryx, MannKind, Novartis, Orexigen, Vivus
Cancer Vaccines and Oncothyreon: Flying Higher as Market Sinks
Seeking Alpha
Thu, 06/16/11 - 11:31 am
Tags:
Oncothyreon, vaccines, cancer, Biovest International, Antigenics, Dendreon, CytRx, ImmunoCellular, Keryx

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.